期刊文献+

胰腺癌侵犯门静脉患者的手术预后评价及相关危险因素分析 被引量:8

Prognosis and related risk factors in patients who underwent surgical resection for pancreatic cancer with portal vein invasion
原文传递
导出
摘要 目的评价门静脉系统侵犯胰腺癌患者手术治疗的预后,并分析其预后的危险因素。方法回顾性分析首都医科大学附属北京朝阳医院肝胆外科2011年1月至2018年12月收治的66例伴有门静脉系统侵犯的胰腺癌患者资料,男性30例,女性36例,年龄范围35~81岁,平均年龄61.5岁。所有患者均接受联合血管切除重建的胰腺癌手术治疗。收集和分析患者病历资料并随访预后情况。Kaplan-Meier法绘制生存曲线,生存率比较采用log-rank检验。多因素Cox回归分析生存预后的危险因素。结果66例患者均顺利完成手术,无围手术期死亡患者,术后发生并发症19例,发生率为28.8%。截止随访结束,共65例(98.5%,65/66)患者获得随访。门静脉系统侵犯胰腺癌患者术后1、2、3年累积生存率分别为53.3%、30.4%、23.4%,中位生存时间为13个月。多因素分析显示,术前糖类抗原19-9>400 U/ml(RR=1.871,95%CI:1.123~3.117)和静脉侵犯全层(RR=1.713,95%CI:1.072~2.736)是门静脉系统侵犯胰腺癌患者生存预后的独立危险因素。分层分析,糖类抗原19-9水平越高,静脉侵犯深度越深,患者的预后越差。结论伴有门静脉系统侵犯的胰腺癌患者远期预后较差,术前糖类抗原19-9>400 U/ml和静脉侵犯全层是患者生存预后的独立危险因素。 ObjectiveTo evaluate the prognosis and related risk factors in patients who underwent surgical resection for pancreatic cancer with portal vein invasion.MethodsThe clinical data of 66 patients with pancreatic cancer with portal vein invasion who underwent pancreatic combined with vascular resection and reconstruction at the Department of Hepatobiliary Surgery,Beijing Chaoyang Hospital Affiliated to Capital Medical University between January 2011 and December 2018 were retrospectively studied.There were 30 males and 36 females.Their age ranged from 35 years to 81 years,with a mean of 61.5 years.Post-operative survival outcomes were evaluated on follow-up,and the related risk factors for prognosis were analyzed.Kaplan-Meier method was used to construct survival curves,and the survival rates were compared by the log-rank test.Multivariate Cox regression was used to analyze prognostic factors.ResultsAll 66 patients successfully underwent the operations.There was no perioperative death.The postoperative complication rate was 28.8%(19/66).Sixty-five patients were followed up(follow-up rate 98.5%,65/66).The overall 1-,2-and 3-year survival rates were 53.3%,30.4%,23.4%,respectively,with a median survival of 13 months.Multivariate analysis showed that preoperative CA19-9>400 U/ml(RR=1.871,95%CI:1.123-3.117)and depth of venous invasion(RR=1.713,95%CI:1.072-2.736)were independent risk factors of prognosis.The higher the preoperative CA19-9,and the deeper the venous invasion,the worse was the prognosis.ConclusionLong-term prognosis of pancreatic carcinoma patients with portal vein invasion was poor.Preoperative CA19-9>400 U/ml and depth of vascular invasion were the main risk factors of prognosis for patients with pancreatic carcinoma and portal vein invasion after surgical resection.
作者 吕少诚 赵昕 李立新 任章勇 曹迪 郎韧 贺强 Lyu Shaocheng;Zhao Xin;Li Lixin;Ren Zhangyong;Cao Di;Lang Ren;He Qiang(Department of Hepatobiliary Surgery,Beijing Chaoyang Hospital Affiliated to Capital Medical University,Beijing 100020,China)
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2020年第9期656-660,共5页 Chinese Journal of Hepatobiliary Surgery
基金 首都临床特色应用研究专项(Z181100001718164)。
关键词 胰腺肿瘤 外科手术 血管侵犯 预后 危险因素 Pancreatic neoplasms Surgical procedures Vascular invasion Prognosis Risk factor
  • 相关文献

参考文献6

二级参考文献32

  • 1吴伟顶,彭承宏,赵大建,周光文,肖卫东,李宏为.联合肠系膜上静脉-门静脉切除在胰腺癌根治术中的作用[J].中华普通外科杂志,2006,21(9):620-622. 被引量:11
  • 2Ramacciato G, Mercantini P, Petrucciani N, et al. Does portal- superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma? [ J ]. Ann Surg Oncol, 2009,16 (4) : 817- 825.
  • 3Sperti C, Berselli M, Pedrazzoli S. Distal panereatectomy for body- tail pancreatic cancer: is there a role for celiac axis resection.'? [ J ]. Panereatology, 2010,10 (4) :491-498.
  • 4Mollberg N,Rahbari NN, Koch M,et al. Arterial resection during pancreateetomy for pancreatic cancer: a systematic review and meta-analysis[ J]. Ann Surg,2011,254(6) :882-893.
  • 5Bassi C, Dervenis C, Buttufini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition [ J ]. Surgery ,2005,138( 1 ) :8-13.
  • 6Winter JM, Cameron JL, Campbell KA, et al. 1423 for pancreatic cancer: A single- institution experience [ J ]. J Gastrointest Surg,2006,10 ( 9 ) : 1199- 1210.
  • 7Fortner JG. Regional resection of cancer of the pancreas: a new surgical approach [ J ]. Surgery, 1973,73 (2) :307-320.
  • 8Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group [ J ]. Ann Surg, 1996,223 ( 2 ) : 154 - 162.
  • 9Leach SD, Lee JE, Charnsangavej C, et al. Survival following with resection of the superior mesenteric portal vein confluence for adenocarcinoma of the pancreatic head [J]. Br J Surg,1998,85(5) :611-617.
  • 10Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindieation for resection? [J]. Ann Surg,1996,224(3) :342-349.

共引文献67

同被引文献55

引证文献8

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部